These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26250941)

  • 1. Do we have sufficient information to optimally inform regulatory or other policy decisions about medications containing codeine?
    Parry CD; Deluca P; Cooper R; Van Hout MC
    Addiction; 2015 Oct; 110(10):1690-1. PubMed ID: 26250941
    [No Abstract]   [Full Text] [Related]  

  • 2. Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between.
    Nielsen S; Van Hout MC
    Curr Top Behav Neurosci; 2017; 34():59-75. PubMed ID: 26768736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caution with the forthcoming rescheduling of over-the-counter codeine-containing analgesics.
    Schug SA; Dobbin MD; Pilgrim JL
    Med J Aust; 2018 Jan; 208(1):51-52. PubMed ID: 29320673
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom.
    Tobin CL; Dobbin M; McAvoy B
    Aust N Z J Public Health; 2013 Oct; 37(5):483-8. PubMed ID: 24090333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-the-counter codeine use in Iceland: the impact of increased access.
    Almarsdóttir AB; Grimsson A
    Scand J Public Health; 2000 Dec; 28(4):270-4. PubMed ID: 11228114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice implications and recommendations for managing codeine misuse and dependence.
    Bergin M; Norman I; Foley M; Harris R; Rapca A; Rich E; Van Hout MC
    Acta Pharm; 2015 Dec; 65(4):351-64. PubMed ID: 26677894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical update: codeine maintenance in opioid dependence.
    Hall WD; Mattick RP
    Lancet; 2007 Aug; 370(9587):550-2. PubMed ID: 17707737
    [No Abstract]   [Full Text] [Related]  

  • 8. Codeine use, dependence and help-seeking behaviour in the UK and Ireland: an online cross-sectional survey.
    Kimergård A; Foley M; Davey Z; Dunne J; Drummond C; Deluca P
    QJM; 2017 Sep; 110(9):559-564. PubMed ID: 28379496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purchasing Over The Counter (OTC) Medicinal Products Containing Codeine - Easy Access, Advertising, Misuse and Perceptions of Medicinal Risk.
    Wells JS; Bergin M; Van Hout MC; McGuinness P; De Pleissisc J; Rich E; Dada S; Wells R; Gooney MA
    J Pharm Pharm Sci; 2018; 21(1):30049. PubMed ID: 30011259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical professionals' perspectives on prescribed and over-the-counter medicines containing codeine: a cross-sectional study.
    Foley M; Carney T; Rich E; Parry C; Van Hout MC; Deluca P
    BMJ Open; 2016 Jul; 6(7):e011725. PubMed ID: 27417200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center.
    Schultz S; Chamberlain C; Vulcan M; Rana H; Patel B; Alexander JC
    J Opioid Manag; 2016; 12(2):119-22. PubMed ID: 27194196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database.
    Fredheim OM; Skurtveit S; Moroz A; Breivik H; Borchgrevink PC
    Acta Anaesthesiol Scand; 2009 May; 53(5):627-33. PubMed ID: 19419357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective cohort study evaluating the impact of upscheduling codeine in Australia among frequent users of codeine.
    McCoy J; Nielsen S; Bruno R
    Addiction; 2022 Mar; 117(3):677-686. PubMed ID: 34490926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescheduling codeine-containing analgesics reduced codeine-related hospital presentations.
    Harris K; Jiang A; Knoeckel R; Isoardi KZ
    Med J Aust; 2020 Apr; 212(7):328. PubMed ID: 31709546
    [No Abstract]   [Full Text] [Related]  

  • 15. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies.
    Van Hout MC; Norman I
    Int J Drug Policy; 2016 Jan; 27():17-22. PubMed ID: 26454626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A spotlight on the role, use, and availability of codeine and the implications faced.
    Tay EMY; Roberts DM
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1057-1059. PubMed ID: 30336710
    [No Abstract]   [Full Text] [Related]  

  • 17. The restrictions to the use of codeine and dilemmas about safe alternatives.
    Carter B; Hawcutt DB; Arnott J
    J Child Health Care; 2013 Dec; 17(4):335-7. PubMed ID: 24336191
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis.
    Boone CG; Antoniou T; Juurlink DN; von den Baumen TR; Kitchen SA; Richards GC; Tadrous M; Gomes T
    CMAJ Open; 2021; 9(4):E1181-E1186. PubMed ID: 34906994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on Cairns et al. (2016): Over-the-counter codeine in Australia-questioning the efficacy of current restrictions or re-scheduling.
    McDonough M
    Addiction; 2016 Oct; 111(10):1854-5. PubMed ID: 27605083
    [No Abstract]   [Full Text] [Related]  

  • 20. Codeine and oxycodone use in patients with chronic rheumatic disease pain.
    Ytterberg SR; Mahowald ML; Woods SR
    Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.